Harmony Biosciences Holdings, Inc. (HRMY)
39.41
+0.20
(+0.51%)
USD |
NASDAQ |
Aug 31, 16:00
39.41
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Cash from Operations (TTM) : 355.08M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 355.08M |
| March 31, 2026 | 341.97M |
| December 31, 2025 | 348.20M |
| September 30, 2025 | 297.61M |
| June 30, 2025 | 259.38M |
| March 31, 2025 | 222.67M |
| December 31, 2024 | 219.82M |
| September 30, 2024 | 220.92M |
| June 30, 2024 | 213.52M |
| March 31, 2024 | 207.97M |
| December 31, 2023 | 219.39M |
| September 30, 2023 | 169.40M |
| June 30, 2023 | 161.50M |
| March 31, 2023 | 158.17M |
| Date | Value |
|---|---|
| December 31, 2022 | 144.47M |
| September 30, 2022 | 155.32M |
| June 30, 2022 | 130.54M |
| March 31, 2022 | 114.88M |
| December 31, 2021 | 98.56M |
| September 30, 2021 | 71.07M |
| June 30, 2021 | 49.48M |
| March 31, 2021 | 36.25M |
| December 31, 2020 | -2.985M |
| September 30, 2020 | -37.02M |
| June 30, 2020 | -69.31M |
| March 31, 2020 | -91.54M |
| December 31, 2019 | -75.44M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Liquidia Corp. | 167.71M |
| Repligen Corp. | 134.86M |
| Johnson & Johnson | 27.61B |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| ANI Pharmaceuticals, Inc. | 189.47M |